login
login

Europe Daily Bulletin No. 13012

2 September 2022
Contents Publication in full By article 23 / 27
EU RESPONSE TO COVID-19 / Health
Covid-19—European Medicines Agency opens door to vaccines adapted to Omicron variant
Brussels, 01/09/2022 (Agence Europe)

On Thursday, 1 September, the Committee for Medicinal Products for Human Use (CHMP) in the European Medicines Agency (EMA) issued two recommendations in favour of conditional marketing authorisation for two Covid-19 vaccines that have been adapted to the Omicron variant.

These vaccines are the Comirnaty vaccine developed by pharmaceutical companies Pfizer and BioNtech and the Spikevax vaccine developed by Moderna. These two messenger RNA vaccines have been adapted in order to provide...

Contents

SECTORAL POLICIES
Russian invasion of Ukraine
INSTITUTIONAL
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
NEWS BRIEFS